Anaesthetic management for descompressive craniectomy in Chiari type I malformation in a patient with suspicion of mast cell activation syndrome

Authors

  • Fátima Ortiz Parra FEA Servicio de Anestesiología, Reanimación y Terapia del Dolor Complejo Hospitalario de Toledo.
  • M González De La Aleja FEA Servicio de Anestesiología, Reanimación y Terapia del Dolor, Hospital Universitario 12 de Octubre, Madrid.
  • Claudia Olea Vielba FEA Servicio de Anestesiología, Reanimación y Terapia del Dolor, Hospital Universitario 12 de Octubre, Madrid.

DOI:

https://doi.org/10.30445/rear.v12i1.803

Keywords:

Craniectomy, Mastocytosis, Anaesthesia, Chiari

Abstract

Mastocytosis is a rare disease whose management must be performed by any anaesthetist because of the clinical consequences that an innapropiate perioperative management may bring.  

Its clinical manifestations are due to the release of histamine and other pro-inflammatory substances holded by mast cells, triggered by multiple elements and many drugs: more specifically, many of the drugs we use in the anaesthetic procedure.

We present the case of a patient with suspicion of mast cell activation syndrome and many certified allergies, who was proposed to be operated on because of a Chiari type 1 malformation with syringomyelia.

References

- Escribano L, Álvarez Twose I, Sánchez Muñoz L et al. Factores desencadenantes de la liberación de mediadores mastocitarios. Protocolos específicos para situaciones de riesgo. Instituto de Estudios de Mastocitosis de Castilla la Mancha (CLMast), Red Española de Mastocitosis (REMA). Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Servicio de Salud de Castilla la Mancha (SESCAM)
Disponible en www.mastocitosis.org/protocolos-de-tratamiento.html [consultada 29/03/2018]

- Dewachter P, Castells M.C, Hepner D. L, Mouton-Fraivre C. Perioperative Management of Patients with Mastocytosis. Anesthesiology 2014; 120:753-9

- Matito A, Morgado JM, Sánchez-López P. Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures. Int Arch Allergy Immunol 2015; 167:47–56

- Unterbuchner C, Hierl M, Seyfried T, Metterlein T. Anaesthesia and orphan disease: Rapid sequence induction in systemic mastocytosis. Eur J Anaesthesiol 2017; 34:176–183

- Ulbrich F, Engelstädter H, Wittau N, Steinmann D. Anaesthetic management of emergency caesarean section in a parturient with systemic mastocytosis. International Journal of Obstetric Anesthesia (2013) 22, 243–254

- Calvo N, Telletxea S, Intxaurraga K, Arízaga A. Mastocitosis sistémica: manejo perioperatorio. A propósito de dos casos. Rev Esp Anestesiol Reanim. 2010; 57 (3): 192-194.

- Maud A.W. Hermans; Nicolette J.T. Arends; Roy Gerth van Wijk. Management around invasive procedures in mastocytosis. An update. Ann Allergy Asthma Immunol 119 (2017) 304-309

- Bonadonna P, Pagani M, Aberer W. Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper. Allergy 2015; 70: 755–763. DOI:10.1111/all.12617

Published

2020-09-10

How to Cite

Ortiz Parra, F., González De La Aleja, M., & Olea Vielba, C. (2020). Anaesthetic management for descompressive craniectomy in Chiari type I malformation in a patient with suspicion of mast cell activation syndrome. Revista Electrónica AnestesiaR, 12(1), 2. https://doi.org/10.30445/rear.v12i1.803